The automated implantable cardioverter-defibrillators (ICDs) are implanted devices inside the body that are able to perform cardioversion, defibrillation, and (in modern versions) pacing of the heart. These devices are therefore capable of correcting most life-threatening cardiac arrhythmias. The ICD is the first-line treatment and prophylactic therapy for patients at risk for sudden cardiac death due to ventricular fibrillation and ventricular tachycardia.
MARKET DYNAMICS
The automated implantable cardioverter defibrillator market is driving due to increasing incidence of cardiovascular diseases and rising demand for sustainable heart solutions. On the other hand, increasing demand for implantable cardioverter defibrillator from emerging countries of Asia-Pacific and the Middle East as cardiovascular disorders are increasing and awareness about the disease also increases in these countries, increasing number of training and awareness programs across the globe for implantable cardioverter defibrillators.
MARKET SCOPE
The "Automated Implantable Cardioverter Defibrillator Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of automated implantable cardioverter defibrillator market with detailed market segmentation by product type, implantation region, and end user. The automated implantable cardioverter defibrillator market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in automated implantable cardioverter defibrillator market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The automated implantable cardioverter defibrillator market is segmented on the basis of product type, implantation region, and end user. Based on product type, the market is segmented as single chambered, dual chambered, and bi-ventricular. On the basis of implantation region, the market is categorized as trans-venous implantable cardioverter defibrillators, and subcutaneous implantable cardioverter defibrillators. Based on end user, the market is segmented into hospitals, specialty clinics and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the automated implantable cardioverter defibrillator market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The automated implantable cardioverter defibrillator market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting automated implantable cardioverter defibrillator market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the automated implantable cardioverter defibrillator market in these regions.
MARKET PLAYERS
The report covers key developments in the automated implantable cardioverter defibrillator market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from automated implantable cardioverter defibrillator market are anticipated to have lucrative growth opportunities in the future with the rising demand for automated implantable cardioverter defibrillator market in the global market. Below mentioned is the list of few companies engaged in the automated implantable cardioverter defibrillator market.
The report also includes the profiles of key players in automated implantable cardioverter defibrillator market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Boston Scientific Corporation
- Imricor Medical Systems, Inc.
- LivaNova PLC
- Medtronic
- MicroPort Scientific Corporation
- Abbott (St. Jude Medical)
- MRI Interventions, Inc.
- BIOTRONIK
- Physio Control
- Nihon Kohden Corporation
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.